The purpose of this registry is to assist CfN researchers in contacting individuals who are interested in participating in any new or ongoing studies being conducted.

What is the purpose of this study?The purpose of this program is to identify, evaluate, study, and follow persons who have Alzheimer's disease, those who have other disorders of memory and thinking, and older individuals who have normal memory and thinking.

Why is this study being done?The interACT Lab at Indiana University is looking for eager, dynamic, and curious youth to participate in the BIRD Study. We want to earn more about the complex relationships between puberty, cognition, social relationships, and health in adolescents. The goal of this study is to gain a further understanding of adolescent brain and behavior. Who can take part?Children and teens ages between 8-16 years old and their parent/legal guardian are eligible to participate. 

Study purposse:  Describe the demographics, risk factors for lung cancer, and baseline Lung Rads score of individuals enrolled in this observational study. Using descriptive statistics, compare the demographics and Lung Rads score of the participants enrolled in this study with those participating in the NLST and NELSON studies. Using descriptive statistics, compare the demographics and Lung Rads score of the participants enrolled in this study with a cohort of participants in the lung screening program at IU HealthParticipants will be recruited by advertisements and at community events. Participants will undergo their lung screening at IU Health fixed lung screening sites or through the IU Health mobile lung screening program.THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.  Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:IU Clinical Trials Office Email: iutrials@iu.edu Phone: (317) 278-5632